MCAFEE, INC. Spending and interest coverage
- R&D / revenue · 12 months: Value 16.76%; Formula and calculation Research and development expense / revenue. Period ending 2010-12-31..
- Stock-based compensation / revenue · 12 months: Value 5.79%; Formula and calculation Share-based compensation / revenue. Period ending 2010-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2010-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 16.76% | Research and development expense / revenue. Period ending 2010-12-31. $346.08M ÷ $2.06B × 100 ≈ 16.76% |
| Stock-based compensation / revenue · 12 months | 5.79% | Share-based compensation / revenue. Period ending 2010-12-31. $119.48M ÷ $2.06B × 100 ≈ 5.79% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 346.08M USD | Research and Development Expense |
| Revenue | 2.06B USD | |
| Stock-based compensation | 119.48M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 229.42M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2010-12-31 | $346.08M | $2.06B | $119.48M | $229.42M | (m) | 16.76% | 5.79% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | $1.98B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $324.37M | $1.93B | $103.04M | $222.31M | (m) | 16.83% | 5.35% | (m) | (m) |
| 2009-09-30 | (m) | $1.83B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | $1.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $252.02M | $1.60B | $76.66M | $189.57M | (m) | 15.75% | 4.79% | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $217.93M | $1.31B | $56.13M | $159.81M | (m) | 16.66% | 4.29% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.